Compare
Agilent Technologies vs Bio-Rad Laboratories (A vs BIO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Agilent Technologies (A) returned +19.1% and Bio-Rad Laboratories (BIO) +23.1%; so far this year the figures are +28.4% and +25.9%.
Agilent Technologies is the larger company by market value, about 4.8 times the size of Bio-Rad Laboratories.
On trailing earnings, A trades at 34.5 times and BIO at 10.1 times.
Revenue grew +8.6% at A and +1.4% at BIO over the last year.
A yields 0.58%. BIO pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| A | BIO | |
|---|---|---|
| Price | $174.76 | $381.57 |
| 1-day | +1.73% | +3.41% |
| YTD | +28.43% | +25.93% |
| 1 year | +19.07% | +23.08% |
| 3 years | +69.90% | +37.50% |
| Market cap | $49.3B | $10.3B |
| P/E | 34.5 | 10.1 |
| P/S | 6.68 | 3.97 |
| P/B | 6.69 | 1.35 |
| Revenue growth | +8.60% | +1.40% |
| EPS growth | +18.70% | — |
| Gross margin % | 53.8 | 51.3 |
| Net margin % | 19.5 | 39.5 |
| ROE % | 19.6 | 13.5 |
| Debt / equity | 0.54 | 0.11 |
| FCF yield % | 2.6 | 3.2 |
| Dividend yield % | 0.58 | — |
| Beta | 0.89 | 0.75 |
| RSI (14) | 53.2 | 56.1 |
| Technical rating |